Bill returned from the Senate with an amendment.

Ordered that the amendment be considered immediately.

Senate’s amendment—

(1)   Schedule 1, page 9 (after line 16), at the end of the Schedule, add:

14  At the end of Part 6-3

Add:

52EC  Review of scheduling regime

        (1)    The Minister must cause an independent review of the operation of this Part to be conducted, with particular reference to the amendments to this Part made by the Therapeutic Goods Amendment (2009 Measures No. 2) Act 2009 (the amendments).

        (2)    The review must:

             (a)    start not later than 1 July 2013; and

             (b)    be completed within 6 months.

        (3)    The review must report on:

             (a)    the system of access controls for goods containing scheduled substances established by this Part;

             (b)    the outcomes of the administration of scheduled substances by the Secretary and by the committees established by this Part;

             (c)    the effect of the amendments on the therapeutic goods industry and on individual parties within the industry;

             (d)    whether there are adequate avenues for review of decisions made by the Secretary and by the committees established by this Part;

and may make recommendations for further changes to the scheduling regime.

        (4)    The review must be conducted by a panel which must comprise not less than three, and not more than five, persons with relevant expertise.

        (5)    As part of the review, the panel must invite and consider public submissions.

        (6)    The panel must give the Minister a written report of the review.

        (7)    The Minister must cause a copy of the report to be laid before each House of the Parliament within 15 sitting days of that House after the day on which the Minister receives the report.